Friday, November 22, 2024
HomeTagsImmVira

ImmVira

ImmVira’s Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma

U.S. time, ImmVira's brand new oncolytic herpes simplex virus ("oHSV") product MVR-C5252 targeting Malignant Glioma has obtained Orphan Drug Designation ("ODD") from U.S. Food...

ImmVira Enters Clinical Development in Combination Therapy of MVR-T3011 IT and MEK Inhibitor in the U.S.

ImmVira announced that, company has reached a cooperation agreement with Roche to establish clinical research partnership recently, to conduct clinical studies in the U.S....

ImmVira’s MVR-T3011 IV completed first 2 cohorts dose-escalation of U.S. Phase I clinical study with favorable safety data

ImmVira's breakthrough product MVR-T3011 IV, global first clinical-stage oncolytic herpes simplex virus (oHSV) via intravenous injection, has recently completed first 2 cohorts dose-escalation of...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics